Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.61 USD | +0.99% | +14.81% | +29.13% |
Financials (USD)
Sales 2024 * | 270M | Sales 2025 * | 120M | Capitalization | 1.74B |
---|---|---|---|---|---|
Net income 2024 * | 77M | Net income 2025 * | 2M | EV / Sales 2024 * | 4.8 x |
Net cash position 2024 * | 442M | Net cash position 2025 * | 677M | EV / Sales 2025 * | 8.84 x |
P/E ratio 2024 * |
25.7
x | P/E ratio 2025 * |
-30.1
x | Employees | 124 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98% |
Latest transcript on Protagonist Therapeutics, Inc.
1 day | +0.99% | ||
1 week | +14.81% | ||
Current month | +17.92% | ||
1 month | +9.50% | ||
3 months | +6.21% | ||
6 months | +79.78% | ||
Current year | +29.13% |
Managers | Title | Age | Since |
---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 67 | 08-11-30 |
Asif Ali
DFI | Director of Finance/CFO | 50 | 22-04-17 |
Chief Tech/Sci/R&D Officer | - | 17-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lewis Williams
BRD | Director/Board Member | 74 | 17-06-07 |
Harold Selick
CHM | Chairman | 69 | 09-01-31 |
Daniel Swisher
BRD | Director/Board Member | 61 | 23-10-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 2 M€ | -.--% | ||
0.05% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.03% | 1,487 M€ | +7.21% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 29.61 | +0.99% | 541,009 |
24-05-13 | 29.32 | +3.86% | 541,028 |
24-05-10 | 28.23 | -0.14% | 513,289 |
24-05-09 | 28.27 | +4.28% | 599,466 |
24-05-08 | 27.11 | +5.12% | 774,657 |
Delayed Quote Nasdaq, May 14, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.13% | 1.72B | |
+29.03% | 48.16B | |
-0.10% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+11.48% | 25.59B | |
-22.74% | 18.96B | |
+9.06% | 12.92B | |
+30.01% | 12.03B | |
-1.51% | 11.77B |
- Stock Market
- Equities
- PTGX Stock